Revolutionizing treatment for chronic conditions
Addressing the biggest challenges in chronic condition therapy
Chariot Biosciences is advancing a next generation cell and gene therapy. The company’s SimmbionsTM are engineered living cellular factories that, with a single injected dose, provide sustained delivery of therapy from inside the patient – replacing the need for frequent injections for many chronic diseases (a key failure point of the current standard of care). SimmbionsTM hold the potential to revolutionize the delivery of therapeutics for chronic conditions.
Our TechnologySustained delivery of therapy
Less cold-chain reliance
Next-gen Cell & Gene Therapy
Our Mission
Chariot Biosciences is transforming the treatment of chronic conditions through innovative cell therapies. Our pioneering Simmbiontm technology enables single injection sustained delivery of life-saving therapeutics, improving long-term outcomes. We strive to redefine the standard of care and enhance quality of life for patients worldwide.
Breakthrough in Chronic Therapeutics
Our Simmbions deliver continuous care without the burden of repeated injections, ensuring steady, precise treatment that fits into everyday life.
Our TechnologyFocus Areas
Chariot Biosciences is advancing Simmbions for the treatment of a wide range of chronic conditions ranging from Gaucher disease, Parkinson’s, diabetes, and cancer.
Gaucher Disease
Chariot's implantable therapeutics offer a groundbreaking approach to managing Gaucher disease by providing continuous treatment that reduces the frequency of enzyme replacement therapy. This innovative solution enhances patient adherence and ensures consistent dosing, leading to improved outcomes and quality of life.
Diabetes
For individuals living with diabetes and obesity, Chariot's technology can deliver steady, precise insulin and/or GLP-1 levels through implantable engineered cells. This method not only simplifies the management of blood glucose levels but also minimizes the inconvenience of frequent injections, allowing patients to focus on their daily lives without the constant interruption of treatment.
Cancer
Chariot's single injection approach for cancer treatment offers a revolutionary solution that can deliver cancer-targeted therapy while avoiding rejection by the patient’s immune system. This universal approach will make cell therapy for cancer more broadly available by eliminating the significant expense of personalized manufacturing required by current approaches.
Chariot Biosciences holds great promise to reduce healthcare costs and significantly enhance the quality of life for those affected by chronic conditions which currently require therapeutics to be delivered by frequent injections.
Chariot Biosciences® is supported by
